Find Scholarly Works

Search concepts
Selected Filters
2019
1 Citation (Scopus)
Sclerosing Cholangitis
Cholangiocarcinoma
Practice Guidelines
Gallbladder Neoplasms
Neoplasms
1 Citation (Scopus)

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Chascsa, D. M. & Lindor, K. D., Sep 1 2019, In : Minerva gastroenterologica e dietologica. 65, 3, p. 214-228 15 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Early Detection of Cancer
Cholangiocarcinoma
Neoplasms
Inflammatory Bowel Diseases
3 Citations (Scopus)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies

Fung, B. M., Lindor, K. & Tabibian, J. H., Feb 14 2019, In : World journal of gastroenterology. 25, 6, p. 659-671 13 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Epidemiology
Neoplasms
End Stage Liver Disease
Cholangiocarcinoma
2 Citations (Scopus)

Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry

Kuo, A., Gomel, R., Safer, R., Lindor, K., Everson, G. T. & Bowlus, C. L., Jun 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 7, p. 1372-1378 7 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Registries
Demography
Patient Reported Outcome Measures
Databases

Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease

Palmer, M., Regev, A., Lindor, K., Avigan, M. I., Dimick-Santos, L., Treem, W., Marcinak, J. F., Lewis, J. H., Anania, F. A., Seekins, D., Shneider, B. L. & Chalasani, N., Jan 1 2019, (Accepted/In press) In : Alimentary Pharmacology and Therapeutics.

Research output: Contribution to journalReview article

Open Access
Chemical and Drug Induced Liver Injury
Practice Guidelines
Liver Diseases
Clinical Trials
Guidelines
2 Citations (Scopus)

Current and promising therapy for primary biliary cholangitis

Gossard, A. A. & Lindor, K., Jun 13 2019, In : Expert Opinion on Pharmacotherapy. 20, 9, p. 1161-1167 7 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Pruritus
Fatigue
Fibrosis
1 Citation (Scopus)

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. & LaRusso, N. F., Jan 1 2019, In : Scandinavian Journal of Gastroenterology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Curcumin
Alkaline Phosphatase
Safety
Serum
2 Citations (Scopus)

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
Cholangitis
Fibrosis
Therapeutics
Survival
Patient Advocacy
2 Citations (Scopus)

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

Esophageal and Gastric Varices
Varicose Veins
ROC Curve
Fibrosis
Digestive System Endoscopy
3 Citations (Scopus)

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

Sclerosing Cholangitis

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

Harms, M. H., De Veer, R. C., Lammers, W. J., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Trivedi, P. J., Hirschfield, G. M., Pares, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Hansen, B. E., Buuren, H. R. V. & 1 others, Van Der Meer, A. J., Jan 1 2019, (Accepted/In press) In : Gut. 319057.

Research output: Contribution to journalArticle

Open Access
Ursodeoxycholic Acid
Numbers Needed To Treat
Cholangitis
Liver Transplantation
Alkaline Phosphatase
9 Citations (Scopus)

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Harms, M. H., van Buuren, H. R., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K., Hirschfield, G. M., Parés, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Lammers, W. J., Hansen, B. E. & van der Meer, A. J., Jan 1 2019, In : Journal of Hepatology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Transplants
Survival
Liver
2017
18 Citations (Scopus)

An update on cancer risk and surveillance in primary sclerosing cholangitis

Horsley-Silva, J. L., Rodriguez, E. A., Franco, D. L. & Lindor, K., 2017, (Accepted/In press) In : Liver International.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Gallbladder Neoplasms
Colorectal Neoplasms
Neoplasms
15 Citations (Scopus)

A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis

Silveira, M. G., Gossard, A. A., Stahler, A. C., Jorgensen, R. A., Petz, J. L., Ali, A. H. & Lindor, K., Mar 1 2017, In : American Journal of Therapeutics. 24, 2, p. e167-e176

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Fatigue
Randomized Controlled Trials
Placebos
Safety
11 Citations (Scopus)

Curcumin in hepatobiliary disease: Pharmacotherapeutic properties and emerging potential clinical applications

Hu, R. W., Carey, E. J., Lindor, K. & Tabibian, J. H., Nov 1 2017, In : Annals of Hepatology. 16, 6, p. 835-841 7 p.

Research output: Contribution to journalArticle

Curcumin
Curcuma
Sclerosing Cholangitis
Rhizome
Cholangiocarcinoma
5 Citations (Scopus)

Emerging treatments for primary sclerosing cholangitis

Rodriguez, E. A., Carey, E. J. & Lindor, K., May 4 2017, In : Expert Review of Gastroenterology and Hepatology. 11, 5, p. 451-459 9 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Therapeutics
End Stage Liver Disease
Cholangiocarcinoma
Inflammatory Bowel Diseases
2 Citations (Scopus)

Heterogeneity of Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis: Age Matters

Martin, P. & Lindor, K., Sep 30 2017, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Liver Transplantation
3 Citations (Scopus)

Investigational drugs in phase II clinical trials for primary biliary cholangitis

Silveira, M. G. & Lindor, K., Oct 3 2017, In : Expert Opinion on Investigational Drugs. 26, 10, p. 1115-1121 7 p.

Research output: Contribution to journalReview article

Investigational Drugs
Phase II Clinical Trials
Cholangitis
Ursodeoxycholic Acid
Fibrosis
2 Citations (Scopus)

Joint society statement for elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Jan 1 2017, In : Annals of Hepatology. 16, 1, p. 6-7 2 p.

Research output: Contribution to journalEditorial

Hepatitis, Viral, Human
Preventive Health Services
Predictive Value of Tests
Medical Societies
Hepatitis
16 Citations (Scopus)

Old and new treatments for primary biliary cholangitis

Chascsa, D., Carey, E. J. & Lindor, K., Apr 1 2017, In : Liver International. 37, 4, p. 490-499 10 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Alkaline Phosphatase
Histology
Chenodeoxycholic Acid
104 Citations (Scopus)

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

on behalf of the & International PSC Study Group, Jun 1 2017, In : Gastroenterology. 152, 8, p. 1975-1984.e8

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Phenotype
Liver Transplantation
Neoplasms
2016
11 Citations (Scopus)

Advances in primary sclerosing cholangitis

Horsley-Silva, J. L., Carey, E. J. & Lindor, K., 2016, In : The Lancet Gastroenterology and Hepatology. 1, 1, p. 68-77 10 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Steatorrhea
Ursodeoxycholic Acid
Cholangiocarcinoma
23 Citations (Scopus)

Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis

Hilscher, M., Enders, F. B., Carey, E. J., Lindor, K. & Tabibian, J. H., Mar 1 2016, In : Annals of Hepatology. 15, 2, p. 246-253 8 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Alkaline Phosphatase
Biomarkers
Survival
Liver Transplantation
309 Citations (Scopus)

A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis

Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., Trauner, M., Jones, D. E., Floreani, A., Hohenester, S., Luketic, V., Shiffman, M., Van Erpecum, K. J., Vargas, V., Vincent, C., Hirschfield, G. M. & 12 others, Shah, H., Hansen, B., Lindor, K., Marschall, H. U., Kowdley, K. V., Hooshmand-Rad, R., Marmon, T., Sheeron, S., Pencek, R., MacConell, L., Pruzanski, M. & Shapiro, D., Aug 18 2016, In : New England Journal of Medicine. 375, 7, p. 631-643 13 p.

Research output: Contribution to journalArticle

Cholangitis
Placebos
Ursodeoxycholic Acid
Bilirubin
Alkaline Phosphatase
10 Citations (Scopus)

Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis

Quinn, K. P., Tabibian, J. H. & Lindor, K., Dec 1 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-5 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Fluorescence In Situ Hybridization
Cholangiocarcinoma
Liver Transplantation
Cholangiography
12 Citations (Scopus)

Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study

Assis, D. N., Abdelghany, O., Cai, S. Y., Gossard, A. A., Eaton, J. E., Keach, J. C., Deng, Y., Setchell, K. D. R., Ciarleglio, M., Lindor, K. & Boyer, J. L., Jul 14 2016, (Accepted/In press) In : Journal of Clinical Gastroenterology.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Tretinoin
Bile Acids and Salts
Alanine Transaminase
5 Citations (Scopus)

Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?

Tabibian, J. H. & Lindor, K., Aug 1 2016, In : Hepatology. 64, 2, p. 340-343 4 p.

Research output: Contribution to journalEditorial

Immunoglobulins
11 Citations (Scopus)

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

Cholangitis
Pharmaceutical Preparations
Ursodeoxycholic Acid
Therapeutics
HLA Antigens
4 Citations (Scopus)

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

Hepatitis
Joints
1 Citation (Scopus)

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

Hepatitis
Joints
9 Citations (Scopus)

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Antibodies
Control Groups
Bilirubin
Alkaline Phosphatase
1 Citation (Scopus)

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

Sclerosing Cholangitis
19 Citations (Scopus)

Obeticholic acid for the treatment of primary biliary cholangitis

Ali, A. H. & Lindor, K., Sep 1 2016, In : Expert Opinion on Pharmacotherapy. 17, 13, p. 1809-1815 7 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Therapeutics
Alkaline Phosphatase
6-ethylchenodeoxycholic acid
3 Citations (Scopus)

Obeticholic Acid in Primary Biliary Cholangitis

Nevens, F., Lindor, K. & Jones, D. E., Nov 17 2016, In : The New England journal of medicine. 375, 20, p. e41

Research output: Contribution to journalLetter

Cholangitis
6 Citations (Scopus)

Oral vancomycin therapy in a child with primary sclerosing cholangitis and severe ulcerative colitis

Buness, C., Lindor, K. & Miloh, T., 2016, In : Pediatric Gastroenterology, Hepatology and Nutrition. 19, 3, p. 210-213 4 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Vancomycin
Ulcerative Colitis
Bile Ducts
Anti-Bacterial Agents
18 Citations (Scopus)

Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)

Chawla, K. S., Talwalkar, J. A., Keach, J. C., Malinchoc, M., Lindor, K. & Jorgensen, R., Dec 31 2016, In : BMJ Open Gastroenterology. 3, 1, e000069.

Research output: Contribution to journalArticle

Fatty Liver
Reproducibility of Results
Liver Diseases
Chronic Disease
Quality of Life
5 Citations (Scopus)

Shifting Paradigms: What Is the True Prevalence and Clinical Course of Primary Sclerosing Cholangitis?

Weersma, R. K. & Lindor, K., Oct 1 2016, In : Gastroenterology. 151, 4, p. 590-593 4 p.

Research output: Contribution to journalEditorial

Sclerosing Cholangitis
65 Citations (Scopus)

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: A multicentre international study

Trivedi, P. J., Lammers, W. J., Van Buuren, H. R., Parés, A., Floreani, A., Janssen, H. L. A., Invernizzi, P., Battezzati, P. M., Ponsioen, C. Y., Corpechot, C., Poupon, R., Mayo, M. J., Burroughs, A. K., Nevens, F., Mason, A. L., Kowdley, K. V., Lleo, A., Caballeria, L., Lindor, K., Hansen, B. E. & 1 others, Hirschfield, G. M., Feb 1 2016, In : Gut. 65, 2, p. 321-329 9 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Multicenter Studies
Hepatocellular Carcinoma
Kaplan-Meier Estimate
North America

Targets and investigative treatments for primary biliary cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Oct 2 2016, In : Expert Opinion on Orphan Drugs. 4, 10, p. 1011-1020 10 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Therapeutics
Phase III Clinical Trials
Phase II Clinical Trials
6 Citations (Scopus)

The management of autoimmunity in patients with cholestatic liver diseases

Ali, A. H., Carey, E. J. & Lindor, K., Jan 2 2016, (Accepted/In press) In : Expert Review of Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

Autoimmunity
Liver Diseases
Autoimmune Diseases
Sclerosing Cholangitis
Cholangitis
5 Citations (Scopus)

The Microbiome and Primary Sclerosing Cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Sep 1 2016, In : Seminars in Liver Disease. 36, 4, p. 340-348 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Microbiota
End Stage Liver Disease
Probiotics
Ulcerative Colitis

Ursodeoxycholic acid treatment in primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., Jan 1 2016, Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Developments. Springer International Publishing, p. 145-152 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ursodeoxycholic Acid
Sclerosing Cholangitis
Liver Diseases
Clinical Trials
Drug Therapy
46 Citations (Scopus)

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

PURIFI Study Group, Jul 1 2016, In : Hepatology. 64, 1, p. 189-199 11 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Alkaline Phosphatase
Bile Acids and Salts
Liver Cirrhosis
2015
169 Citations (Scopus)

ACG clinical guideline: Primary sclerosing cholangitis

Lindor, K., Kowdley, K. V. & Harrison, M. E., May 8 2015, In : American Journal of Gastroenterology. 110, 5, p. 646-659 14 p.

Research output: Contribution to journalArticle

Bile Duct Neoplasms
Avitaminosis
Ursodeoxycholic Acid
Sclerosing Cholangitis
Metabolic Bone Diseases
17 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Oct 1 2015, In : Clinics and Research in Hepatology and Gastroenterology. 39, 5, p. e57-e59 800.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Terminology
Fibrosis
10 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Digestive and Liver Disease. 47, 11, p. 924-926 3 p., 2950.

Research output: Contribution to journalArticle

21st Century History
19th Century History
20th Century History
Cholangitis
Biliary Liver Cirrhosis
68 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Hepatology. 62, 5, p. 1620-1622 3 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Gut. 64, 11, p. 1671-1672 2 p.

Research output: Contribution to journalArticle

44 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Journal of Hepatology. 63, 5, p. 1285-1287 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Disease Progression
21 Citations (Scopus)

Changing nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : American Journal of Gastroenterology. 110, 11, p. 1536-1538 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Patient Preference
Terminology
Fibrosis